SE332175B - - Google Patents

Info

Publication number
SE332175B
SE332175B SE03661/65A SE366165A SE332175B SE 332175 B SE332175 B SE 332175B SE 03661/65 A SE03661/65 A SE 03661/65A SE 366165 A SE366165 A SE 366165A SE 332175 B SE332175 B SE 332175B
Authority
SE
Sweden
Application number
SE03661/65A
Inventor
T Takano
K Hattori
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1427664A external-priority patent/JPS435888B1/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE332175B publication Critical patent/SE332175B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE03661/65A 1964-03-14 1965-03-15 SE332175B (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1427664A JPS435888B1 (enExample) 1964-03-14 1964-03-14
JP4212864 1964-07-23

Publications (1)

Publication Number Publication Date
SE332175B true SE332175B (enExample) 1971-02-01

Family

ID=26350190

Family Applications (1)

Application Number Title Priority Date Filing Date
SE03661/65A SE332175B (enExample) 1964-03-14 1965-03-15

Country Status (4)

Country Link
US (1) US3453272A (enExample)
FR (1) FR5396M (enExample)
GB (1) GB1058535A (enExample)
SE (1) SE332175B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497039A (en) * 1973-12-05 1978-01-05 Glaxo Lab Ltd Penicillins and cephalosporins
US3931159A (en) * 1974-03-18 1976-01-06 American Home Products Corporation Substituted 3-benzoylacrylamido-cephalosporanic acid derivative
DE2755480A1 (de) * 1977-12-13 1979-06-21 Siemens Ag Verfahren zur herstellung einer integrierten halbleiterschaltung
JPS57188595A (en) * 1981-05-14 1982-11-19 Meiji Seika Kaisha Ltd 7alpha-methoxycephem compound and its preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236841A (en) * 1961-11-22 1966-02-22 Merck & Co Inc 7-acylaminocephalosporanic acids

Also Published As

Publication number Publication date
GB1058535A (en) 1967-02-15
US3453272A (en) 1969-07-01
DE1545796B2 (de) 1975-08-14
FR5396M (enExample) 1967-09-25
DE1545796A1 (de) 1969-10-16

Similar Documents

Publication Publication Date Title
BE659255A (enExample)
BE610935A (enExample)
BE432268A (enExample)
BE47396A (enExample)
BE483969A (enExample)
BE507097A (enExample)
BE518974A (enExample)
BE554195A (enExample)
BE564626A (enExample)
BE584699A (enExample)
BE603534A (enExample)
BE658576A (enExample)
BE613833A (enExample)
BE621510A (enExample)
BE622126A (enExample)
BE623398A (enExample)
BE626083A (enExample)
BE626684A (enExample)
BE627057A (enExample)
BE627390A (enExample)
BE627931A (enExample)
BE628611A (enExample)
BE629793A (enExample)
BE632875A (enExample)
BE636791A (enExample)